| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromo shadow domain binding | 5.39e-07 | 6 | 61 | 3 | GO:0070087 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.39e-04 | 86 | 61 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.52e-04 | 88 | 61 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone binding | 1.56e-04 | 265 | 61 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.14e-04 | 206 | 61 | 5 | GO:0140030 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.49e-06 | 217 | 61 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.29e-05 | 175 | 61 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.29e-05 | 175 | 61 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.42e-05 | 178 | 61 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | mRNA localization resulting in post-transcriptional regulation of gene expression | 5.14e-05 | 4 | 61 | 2 | GO:0010609 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 6.82e-05 | 74 | 61 | 4 | GO:0006406 | |
| GeneOntologyBiologicalProcess | mRNA transport | 6.94e-05 | 145 | 61 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 9.29e-05 | 249 | 61 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.10e-04 | 502 | 61 | 8 | GO:0008380 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.88e-04 | 96 | 61 | 4 | GO:0006405 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.18e-04 | 185 | 61 | 5 | GO:0051168 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 3.09e-04 | 741 | 61 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 3.34e-04 | 203 | 61 | 5 | GO:0045814 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 4.25e-04 | 330 | 61 | 6 | GO:0040029 | |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 4.65e-04 | 11 | 61 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 4.65e-04 | 11 | 61 | 2 | GO:0071481 | |
| GeneOntologyCellularComponent | nuclear body | SRRM1 RGS14 ZNF106 SP100 TCF20 ATRX PNN RBBP6 CBX1 KMT2E THOC2 YTHDC1 PRPF40A | 1.60e-06 | 903 | 61 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | JARID2 SRRM1 ELOA SP100 PNN MTF2 SUPT6H CDC20B UPF3B KMT2E THOC2 NIPBL PRPF40A XRCC6 SMG6 | 7.00e-06 | 1377 | 61 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | chromosome, telomeric region | 1.24e-05 | 176 | 61 | 6 | GO:0000781 | |
| GeneOntologyCellularComponent | chromosomal region | 2.93e-05 | 421 | 61 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 3.03e-05 | 21 | 61 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | nuclear speck | 3.46e-05 | 431 | 61 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | smooth muscle contractile fiber | 8.33e-05 | 5 | 61 | 2 | GO:0030485 | |
| GeneOntologyCellularComponent | ESC/E(Z) complex | 1.11e-03 | 17 | 61 | 2 | GO:0035098 | |
| Domain | ZF_PHD_2 | 6.54e-07 | 95 | 61 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 6.96e-07 | 96 | 61 | 6 | PS01359 | |
| Domain | Znf_FYVE_PHD | 8.34e-06 | 147 | 61 | 6 | IPR011011 | |
| Domain | PHD | 1.06e-05 | 89 | 61 | 5 | SM00249 | |
| Domain | Znf_PHD | 1.18e-05 | 91 | 61 | 5 | IPR001965 | |
| Domain | Zinc_finger_PHD-type_CS | 6.01e-05 | 65 | 61 | 4 | IPR019786 | |
| Domain | - | 6.30e-04 | 449 | 61 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 7.18e-04 | 459 | 61 | 7 | IPR013083 | |
| Domain | PHD | 1.89e-03 | 75 | 61 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.20e-03 | 79 | 61 | 3 | IPR019787 | |
| Domain | - | 2.32e-03 | 22 | 61 | 2 | 1.10.196.10 | |
| Domain | EPHD | 2.32e-03 | 22 | 61 | 2 | PS51805 | |
| Domain | RGS_subdom1 | 2.32e-03 | 22 | 61 | 2 | IPR024066 | |
| Domain | ZnF_U1 | 4.02e-03 | 29 | 61 | 2 | SM00451 | |
| Domain | Znf_U1 | 4.02e-03 | 29 | 61 | 2 | IPR003604 | |
| Domain | SNF2_N | 4.89e-03 | 32 | 61 | 2 | IPR000330 | |
| Domain | SNF2_N | 4.89e-03 | 32 | 61 | 2 | PF00176 | |
| Domain | RGS | 5.83e-03 | 35 | 61 | 2 | PF00615 | |
| Domain | RGS | 5.83e-03 | 35 | 61 | 2 | SM00315 | |
| Domain | RGS | 6.15e-03 | 36 | 61 | 2 | PS50132 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 SEC16B ELOA ZNF106 LIMA1 TCF20 ATRX PNN ZNF592 RBBP6 CKAP5 THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 2.48e-13 | 774 | 61 | 16 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPALPP1 ELOA LIMA1 ATRX PNN RBBP6 PRRC2C CKAP5 CBX1 RAI14 UPF3B THOC2 NIPBL PRPF40A XRCC6 AHNAK2 | 4.22e-12 | 934 | 61 | 16 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SRRM1 ELOA TCF20 ATRX MTF2 ZNF592 ZNF483 GPATCH11 SHPRH CBX1 NIPBL XRCC6 | 5.84e-10 | 608 | 61 | 12 | 36089195 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SP100 LIMA1 MYH11 SUPT6H PRRC2C CAMK2G CKAP5 HKDC1 UPF3B THOC2 NIPBL PRPF40A XRCC6 | 2.16e-09 | 847 | 61 | 13 | 35235311 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG SRRM1 ELOA TCF20 PNN RBBP6 SUPT6H ZNF423 CBX1 THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 4.22e-09 | 1082 | 61 | 14 | 38697112 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRM1 ZNF106 TCF20 ATRX PNN MTF2 RBBP6 SUPT6H CKAP5 NKTR THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 4.72e-09 | 1294 | 61 | 15 | 30804502 |
| Pubmed | 7.16e-09 | 335 | 61 | 9 | 15741177 | ||
| Pubmed | JARID2 ATRX MTF2 ZNF592 RBBP6 SUPT6H PRRC2C GPATCH11 UPF3B YTHDC1 | 8.82e-09 | 469 | 61 | 10 | 27634302 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.37e-08 | 361 | 61 | 9 | 26167880 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ELOA ZNF106 SP100 TCF20 TXNDC5 PNN RBBP6 CAMK2G CKAP5 CBX1 KMT2E THOC2 YTHDC1 PRPF40A | 1.61e-08 | 1203 | 61 | 14 | 29180619 |
| Pubmed | SRRM1 ELOA TCF20 ATRX PNN ZNF592 RBBP6 SUPT6H THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 1.83e-08 | 1014 | 61 | 13 | 32416067 | |
| Pubmed | GPALPP1 FLG SRRM1 RGS14 ELOA SP100 LIMA1 MYH11 ATRX PNN PRRC2C CAMK2G HKDC1 NIPBL XRCC6 | 2.00e-08 | 1442 | 61 | 15 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP350 SRRM1 LIMA1 TCF20 TXNDC5 PNN SUPT6H CKAP5 CBX1 THOC2 NIPBL PRPF40A XRCC6 | 2.06e-08 | 1024 | 61 | 13 | 24711643 |
| Pubmed | SRRM1 ELOA PNN RBBP6 PRRC2C RAI14 NKTR UPF3B THOC2 YTHDC1 PRPF40A | 4.10e-08 | 713 | 61 | 11 | 29802200 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SRRM1 LIMA1 MYH11 NF2 PNN RBBP6 RAI14 UPF3B THOC2 YTHDC1 PRPF40A XRCC6 | 8.10e-08 | 949 | 61 | 12 | 36574265 |
| Pubmed | CEP350 SRRM1 SEC16B ELOA MYH11 TXNDC5 PRRC2C GPATCH11 RAI14 NKTR UPF3B THOC2 PRPF40A XRCC6 | 8.13e-08 | 1371 | 61 | 14 | 36244648 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRM1 ELOA TCF20 ATRX PNN RBBP6 PRRC2C CBX1 THOC2 NIPBL PRPF40A XRCC6 | 8.58e-08 | 954 | 61 | 12 | 36373674 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 9.58e-08 | 605 | 61 | 10 | 28977666 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.15e-07 | 330 | 61 | 8 | 33301849 | |
| Pubmed | FLG LIMA1 TCF20 ATRX PNN ZNF592 RBBP6 PRRC2C CBX1 RAI14 MLLT10 NIPBL PRPF40A XRCC6 | 1.35e-07 | 1429 | 61 | 14 | 35140242 | |
| Pubmed | 1.44e-07 | 340 | 61 | 8 | 24332808 | ||
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 1.62e-07 | 138 | 61 | 6 | 37506885 | |
| Pubmed | CEP350 GPALPP1 SRRM1 ZNF592 CKAP5 SHPRH RAI14 UPF3B THOC2 XRCC6 | 1.73e-07 | 645 | 61 | 10 | 25281560 | |
| Pubmed | SRRM1 TCF20 PNN SUPT6H PRRC2C CKAP5 THOC2 NIPBL PRPF40A XRCC6 | 1.94e-07 | 653 | 61 | 10 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ELOA SP100 LIMA1 PNN RBBP6 PRRC2C CAMK2G CKAP5 CBX1 RAI14 THOC2 YTHDC1 XRCC6 | 2.21e-07 | 1257 | 61 | 13 | 36526897 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP350 SRRM1 ZNF106 LIMA1 TCF20 PRRC2C KCTD8 CKAP5 RAI14 CFAP97 AHNAK2 | 2.72e-07 | 861 | 61 | 11 | 36931259 |
| Pubmed | CEP350 NRCAM TRAF3IP1 ATRX NF2 ZNF592 ZNF423 CKAP5 RAI14 NCKAP5 LRP1B NIPBL XRCC6 | 2.84e-07 | 1285 | 61 | 13 | 35914814 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.73e-07 | 533 | 61 | 9 | 30554943 | |
| Pubmed | 4.77e-07 | 549 | 61 | 9 | 38280479 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.57e-07 | 283 | 61 | 7 | 30585729 | |
| Pubmed | 7.78e-07 | 425 | 61 | 8 | 24999758 | ||
| Pubmed | 1.08e-06 | 103 | 61 | 5 | 32744500 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SRRM1 PNN RBBP6 SUPT6H PRRC2C UPF3B ZNF385A YTHDC1 PRPF40A XRCC6 | 1.33e-06 | 807 | 61 | 10 | 22681889 |
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 15882967 | ||
| Pubmed | SRRM1 LIMA1 TXNDC5 NF2 PNN RBBP6 RAI14 UPF3B THOC2 YTHDC1 PRPF40A XRCC6 | 1.47e-06 | 1247 | 61 | 12 | 27684187 | |
| Pubmed | 1.78e-06 | 114 | 61 | 5 | 31553912 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.84e-06 | 477 | 61 | 8 | 31300519 | |
| Pubmed | 1.90e-06 | 332 | 61 | 7 | 25693804 | ||
| Pubmed | 2.11e-06 | 486 | 61 | 8 | 20936779 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.11e-06 | 486 | 61 | 8 | 30940648 | |
| Pubmed | 2.18e-06 | 660 | 61 | 9 | 32780723 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.46e-06 | 670 | 61 | 9 | 22990118 | |
| Pubmed | 2.62e-06 | 222 | 61 | 6 | 37071664 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9736627 | ||
| Pubmed | Generation of Pecam1 endothelial specific dual reporter mouse model. | 3.03e-06 | 2 | 61 | 2 | 32618127 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 33887196 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.13e-06 | 358 | 61 | 7 | 32460013 | |
| Pubmed | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. | 3.38e-06 | 58 | 61 | 4 | 20935630 | |
| Pubmed | 3.55e-06 | 234 | 61 | 6 | 36243803 | ||
| Pubmed | 5.80e-06 | 255 | 61 | 6 | 15324660 | ||
| Pubmed | LIMA1 TCF20 NRCAM TRAF3IP1 PRRC2C CAMK2G CKAP5 NIPBL XRCC6 SMG6 | 6.34e-06 | 963 | 61 | 10 | 28671696 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ELOA ZNF106 TCF20 TXNDC5 ZNF592 SUPT6H THOC2 YTHDC1 PRPF40A XRCC6 | 8.00e-06 | 989 | 61 | 10 | 36424410 |
| Pubmed | 8.73e-06 | 419 | 61 | 7 | 15635413 | ||
| Pubmed | 8.74e-06 | 274 | 61 | 6 | 34244482 | ||
| Pubmed | 8.85e-06 | 591 | 61 | 8 | 15231748 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21732481 | ||
| Pubmed | JARID2 ATRX ZNF592 RBBP6 SUPT6H CKAP5 CBX1 RAI14 ZNF385A YTHDC1 NIPBL SMG6 | 9.52e-06 | 1497 | 61 | 12 | 31527615 | |
| Pubmed | 1.22e-05 | 441 | 61 | 7 | 31239290 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 1.56e-05 | 85 | 61 | 4 | 16051665 | |
| Pubmed | 1.57e-05 | 304 | 61 | 6 | 32235678 | ||
| Pubmed | 1.61e-05 | 847 | 61 | 9 | 35850772 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GPALPP1 SRRM1 PNN RBBP6 CBX1 NKTR THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 1.63e-05 | 1318 | 61 | 11 | 30463901 |
| Pubmed | 1.79e-05 | 183 | 61 | 5 | 36129980 | ||
| Pubmed | 1.79e-05 | 652 | 61 | 8 | 31180492 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 9636146 | ||
| Pubmed | Expression of the Nkx3.1 homobox gene during pre and postnatal development. | 1.81e-05 | 4 | 61 | 2 | 10415359 | |
| Pubmed | Nipbl Haploinsufficiency Leads to Delayed Outflow Tract Septation and Aortic Valve Thickening. | 1.81e-05 | 4 | 61 | 2 | 37958548 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 20150414 | ||
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 2.04e-05 | 91 | 61 | 4 | 34780483 | |
| Pubmed | GPALPP1 TCF20 TXNDC5 PRRC2C CAMK2G CKAP5 UPF3B THOC2 NIPBL XRCC6 | 2.05e-05 | 1103 | 61 | 10 | 34189442 | |
| Pubmed | 2.42e-05 | 491 | 61 | 7 | 36273042 | ||
| Pubmed | 2.66e-05 | 689 | 61 | 8 | 36543142 | ||
| Pubmed | 2.82e-05 | 503 | 61 | 7 | 16964243 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 2.83e-05 | 910 | 61 | 9 | 36736316 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 21209221 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CEP350 ZNF106 TRAF3IP1 GPATCH11 CKAP5 CBX1 RAI14 NIPBL XRCC6 CFAP97 | 3.04e-05 | 1155 | 61 | 10 | 20360068 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | JARID2 TXNDC5 ATRX PNN SUPT6H CKAP5 UPF3B THOC2 NIPBL PRPF40A XRCC6 | 3.34e-05 | 1425 | 61 | 11 | 30948266 |
| Pubmed | 3.46e-05 | 210 | 61 | 5 | 16565220 | ||
| Pubmed | 4.04e-05 | 731 | 61 | 8 | 29298432 | ||
| Pubmed | 4.05e-05 | 360 | 61 | 6 | 33111431 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 4.12e-05 | 361 | 61 | 6 | 30344098 | |
| Pubmed | 4.15e-05 | 38 | 61 | 3 | 28680062 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 4.22e-05 | 536 | 61 | 7 | 15840001 | |
| Pubmed | 4.32e-05 | 538 | 61 | 7 | 10512203 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 12554878 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.26e-05 | 759 | 61 | 8 | 35915203 | |
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 20123894 | ||
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 34818545 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 6.32e-05 | 7 | 61 | 2 | 23415230 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.68e-05 | 394 | 61 | 6 | 27248496 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 7.07e-05 | 582 | 61 | 7 | 20467437 | |
| Pubmed | 7.16e-05 | 399 | 61 | 6 | 35987950 | ||
| Pubmed | 7.38e-05 | 46 | 61 | 3 | 21102462 | ||
| Pubmed | 7.88e-05 | 47 | 61 | 3 | 18821565 | ||
| Pubmed | 8.14e-05 | 808 | 61 | 8 | 20412781 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 8.25e-05 | 130 | 61 | 4 | 35545047 | |
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 9933612 | ||
| Pubmed | The identification of different endothelial cell populations within the mouse proepicardium. | 8.42e-05 | 8 | 61 | 2 | 21932312 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.83e-05 | 256 | 61 | 5 | 33397691 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 9.16e-05 | 258 | 61 | 5 | 37794589 | |
| Interaction | MECP2 interactions | FLG SRRM1 ELOA SP100 TCF20 ATRX PNN RBBP6 SUPT6H ZNF423 CAMK2G ZNF483 CBX1 NKTR THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 3.94e-09 | 1287 | 61 | 19 | int:MECP2 |
| Interaction | NAA40 interactions | GPALPP1 ELOA LIMA1 ATRX PNN RBBP6 PRRC2C CKAP5 CBX1 RAI14 UPF3B THOC2 NIPBL PRPF40A XRCC6 AHNAK2 | 2.17e-08 | 978 | 61 | 16 | int:NAA40 |
| Interaction | CIT interactions | SRRM1 LIMA1 MYH11 TCF20 NF2 PNN RBBP6 SUPT6H PRRC2C CKAP5 CBX1 RAI14 NKTR UPF3B THOC2 NIPBL PRPF40A XRCC6 AHNAK2 | 2.74e-08 | 1450 | 61 | 19 | int:CIT |
| Interaction | SSRP1 interactions | SRRM1 ELOA ATRX NF2 PNN ZNF592 RBBP6 SUPT6H MLLT10 YTHDC1 NIPBL PRPF40A XRCC6 | 1.05e-07 | 685 | 61 | 13 | int:SSRP1 |
| Interaction | DHX8 interactions | 2.23e-07 | 292 | 61 | 9 | int:DHX8 | |
| Interaction | NUP43 interactions | GPALPP1 SRRM1 TCF20 PNN ZNF592 RBBP6 SUPT6H PRRC2C NKTR YTHDC1 NIPBL AHNAK2 | 3.09e-07 | 625 | 61 | 12 | int:NUP43 |
| Interaction | CHD4 interactions | FLG SRRM1 ELOA TCF20 PNN MTF2 ZNF592 RBBP6 SUPT6H PRRC2C SHPRH CBX1 PRPF40A XRCC6 | 5.92e-07 | 938 | 61 | 14 | int:CHD4 |
| Interaction | TERF2IP interactions | ELOA SP100 TCF20 ZNF592 RBBP6 SUPT6H CBX1 THOC2 NIPBL PRPF40A XRCC6 | 7.13e-07 | 552 | 61 | 11 | int:TERF2IP |
| Interaction | ZNF330 interactions | ELOA ZNF106 TCF20 MTF2 ZNF592 SUPT6H SHPRH YTHDC1 NIPBL XRCC6 | 8.38e-07 | 446 | 61 | 10 | int:ZNF330 |
| Interaction | TOP1 interactions | SRRM1 SP100 TCF20 NF2 PNN RBBP6 SUPT6H CKAP5 YTHDC1 NIPBL PRPF40A XRCC6 | 9.66e-07 | 696 | 61 | 12 | int:TOP1 |
| Interaction | CSNK2A2 interactions | SRRM1 ELOA ZNF106 TCF20 ATRX PNN ZNF592 PRRC2C NKTR PRPF40A CFAP97 AHNAK2 | 1.34e-06 | 718 | 61 | 12 | int:CSNK2A2 |
| Interaction | DDX23 interactions | GPALPP1 SRRM1 ELOA PNN RBBP6 SUPT6H NKTR THOC2 YTHDC1 PRPF40A | 1.63e-06 | 480 | 61 | 10 | int:DDX23 |
| Interaction | H3C3 interactions | 2.14e-06 | 495 | 61 | 10 | int:H3C3 | |
| Interaction | KIF20A interactions | SRRM1 ZNF106 LIMA1 MYH11 NF2 PNN RBBP6 SUPT6H RAI14 THOC2 PRPF40A XRCC6 AHNAK2 SMG6 | 2.30e-06 | 1052 | 61 | 14 | int:KIF20A |
| Interaction | YWHAG interactions | CEP350 SRRM1 ZNF106 LIMA1 TXNDC5 PNN PRRC2C CAMK2G CKAP5 SHPRH RAI14 NKTR PRPF40A CFAP97 AHNAK2 | 3.29e-06 | 1248 | 61 | 15 | int:YWHAG |
| Interaction | PNN interactions | 3.43e-06 | 302 | 61 | 8 | int:PNN | |
| Interaction | SAP18 interactions | 3.69e-06 | 305 | 61 | 8 | int:SAP18 | |
| Interaction | YWHAH interactions | CEP350 SRRM1 ZNF106 LIMA1 MYH11 TCF20 PNN PRRC2C CAMK2G CKAP5 RAI14 NKTR CFAP97 AHNAK2 | 3.96e-06 | 1102 | 61 | 14 | int:YWHAH |
| Interaction | EED interactions | JARID2 SRRM1 LIMA1 MYH11 TXNDC5 PNN MTF2 RBBP6 SUPT6H CKAP5 SHPRH RAI14 THOC2 NIPBL PRPF40A XRCC6 | 4.15e-06 | 1445 | 61 | 16 | int:EED |
| Interaction | CSNK2A1 interactions | FLG SRRM1 ATRX PNN ZNF592 SUPT6H PRRC2C CBX1 NKTR UPF3B PRPF40A XRCC6 CFAP97 | 4.48e-06 | 956 | 61 | 13 | int:CSNK2A1 |
| Interaction | DOT1L interactions | SRRM1 LIMA1 ATRX PNN ZNF592 RBBP6 CKAP5 RAI14 MLLT10 THOC2 YTHDC1 PRPF40A | 4.48e-06 | 807 | 61 | 12 | int:DOT1L |
| Interaction | RNPS1 interactions | 4.98e-06 | 425 | 61 | 9 | int:RNPS1 | |
| Interaction | CDX2 interactions | 6.20e-06 | 86 | 61 | 5 | int:CDX2 | |
| Interaction | SNRPC interactions | 6.59e-06 | 440 | 61 | 9 | int:SNRPC | |
| Interaction | THRAP3 interactions | 6.96e-06 | 443 | 61 | 9 | int:THRAP3 | |
| Interaction | H2BC8 interactions | 8.17e-06 | 576 | 61 | 10 | int:H2BC8 | |
| Interaction | IFI16 interactions | SRRM1 ELOA SP100 PNN CKAP5 CBX1 RAI14 UPF3B YTHDC1 PRPF40A XRCC6 | 8.50e-06 | 714 | 61 | 11 | int:IFI16 |
| Interaction | SRPK2 interactions | SRRM1 SEC16B PNN ZNF592 RBBP6 SUPT6H PRRC2C NKTR UPF3B YTHDC1 PRPF40A | 8.84e-06 | 717 | 61 | 11 | int:SRPK2 |
| Interaction | NKAPD1 interactions | 9.15e-06 | 161 | 61 | 6 | int:NKAPD1 | |
| Interaction | GPALPP1 interactions | 9.42e-06 | 44 | 61 | 4 | int:GPALPP1 | |
| Interaction | CHMP4B interactions | SRRM1 LIMA1 MYH11 ATRX NF2 PNN CKAP5 CBX1 RAI14 XRCC6 AHNAK2 | 1.01e-05 | 727 | 61 | 11 | int:CHMP4B |
| Interaction | KIF23 interactions | FLG SRRM1 LIMA1 MYH11 TXNDC5 PNN CAMK2G HKDC1 RAI14 THOC2 PRPF40A XRCC6 AHNAK2 | 1.01e-05 | 1031 | 61 | 13 | int:KIF23 |
| Interaction | TNIP1 interactions | FLG SRRM1 ELOA LIMA1 MYH11 NF2 PNN RBBP6 RAI14 UPF3B THOC2 YTHDC1 PRPF40A XRCC6 | 1.23e-05 | 1217 | 61 | 14 | int:TNIP1 |
| Interaction | H3-3A interactions | ELOA TCF20 ATRX ZNF592 ZNF483 GPATCH11 CKAP5 SHPRH CBX1 NIPBL XRCC6 | 1.33e-05 | 749 | 61 | 11 | int:H3-3A |
| Interaction | SNRPA interactions | 1.37e-05 | 482 | 61 | 9 | int:SNRPA | |
| Interaction | OBSL1 interactions | SRRM1 LIMA1 TCF20 TXNDC5 PNN SUPT6H CBX1 THOC2 YTHDC1 NIPBL PRPF40A XRCC6 | 1.38e-05 | 902 | 61 | 12 | int:OBSL1 |
| Interaction | EWSR1 interactions | GPALPP1 JARID2 SRRM1 TCF20 MTF2 RBBP6 GPATCH11 RAI14 LRP1B NIPBL PRPF40A XRCC6 | 1.44e-05 | 906 | 61 | 12 | int:EWSR1 |
| Interaction | RNF4 interactions | ELOA ZNF106 SP100 LIMA1 TCF20 TXNDC5 PNN RBBP6 CAMK2G CKAP5 CBX1 KMT2E THOC2 YTHDC1 PRPF40A | 1.46e-05 | 1412 | 61 | 15 | int:RNF4 |
| Interaction | BRD3 interactions | 1.66e-05 | 494 | 61 | 9 | int:BRD3 | |
| Interaction | EIF4A3 interactions | 1.80e-05 | 499 | 61 | 9 | int:EIF4A3 | |
| Interaction | ANKRD50 interactions | 1.89e-05 | 108 | 61 | 5 | int:ANKRD50 | |
| Interaction | CBX3 interactions | 2.20e-05 | 646 | 61 | 10 | int:CBX3 | |
| Interaction | SNRPB interactions | 2.38e-05 | 517 | 61 | 9 | int:SNRPB | |
| Interaction | ZFP41 interactions | 2.66e-05 | 57 | 61 | 4 | int:ZFP41 | |
| Interaction | CLK2 interactions | 2.71e-05 | 195 | 61 | 6 | int:CLK2 | |
| Interaction | CPSF6 interactions | 2.72e-05 | 526 | 61 | 9 | int:CPSF6 | |
| Interaction | PARP1 interactions | SRRM1 ELOA ZNF106 NF2 PNN MTF2 SUPT6H ZNF423 SHPRH CBX1 YTHDC1 NIPBL PRPF40A XRCC6 | 2.96e-05 | 1316 | 61 | 14 | int:PARP1 |
| Interaction | SUPT5H interactions | 3.04e-05 | 408 | 61 | 8 | int:SUPT5H | |
| Interaction | SNRNP70 interactions | SRRM1 ELOA PNN RBBP6 PRRC2C RAI14 NKTR UPF3B THOC2 YTHDC1 PRPF40A IFIT3 | 3.26e-05 | 984 | 61 | 12 | int:SNRNP70 |
| Interaction | SNRPA1 interactions | 3.31e-05 | 300 | 61 | 7 | int:SNRPA1 | |
| Interaction | SNIP1 interactions | 3.55e-05 | 417 | 61 | 8 | int:SNIP1 | |
| Interaction | SMC5 interactions | SRRM1 ELOA TCF20 ATRX PNN RBBP6 PRRC2C CBX1 THOC2 NIPBL PRPF40A XRCC6 | 3.82e-05 | 1000 | 61 | 12 | int:SMC5 |
| Interaction | FUBP1 interactions | 4.00e-05 | 309 | 61 | 7 | int:FUBP1 | |
| Interaction | SRSF7 interactions | 4.06e-05 | 425 | 61 | 8 | int:SRSF7 | |
| Interaction | H2BC21 interactions | 4.15e-05 | 696 | 61 | 10 | int:H2BC21 | |
| Interaction | ERLEC1 interactions | 4.28e-05 | 128 | 61 | 5 | int:ERLEC1 | |
| Interaction | MYCN interactions | SRRM1 ZNF106 LIMA1 TCF20 PNN RBBP6 PRRC2C UPF3B ZNF385A THOC2 YTHDC1 PRPF40A XRCC6 SMG6 | 4.72e-05 | 1373 | 61 | 14 | int:MYCN |
| Interaction | DDX39B interactions | 5.09e-05 | 570 | 61 | 9 | int:DDX39B | |
| Interaction | H2BC12 interactions | 5.19e-05 | 322 | 61 | 7 | int:H2BC12 | |
| Interaction | RBBP4 interactions | 5.30e-05 | 573 | 61 | 9 | int:RBBP4 | |
| Interaction | RBM39 interactions | SRRM1 SP100 LIMA1 MYH11 ATRX PNN PRRC2C GPATCH11 NKTR KMT2E PRPF40A XRCC6 | 5.69e-05 | 1042 | 61 | 12 | int:RBM39 |
| Interaction | MAU2 interactions | 5.71e-05 | 136 | 61 | 5 | int:MAU2 | |
| Interaction | GATAD2A interactions | 5.88e-05 | 224 | 61 | 6 | int:GATAD2A | |
| Interaction | ZBTB2 interactions | 6.06e-05 | 450 | 61 | 8 | int:ZBTB2 | |
| Interaction | CCDC71 interactions | 6.70e-05 | 72 | 61 | 4 | int:CCDC71 | |
| Interaction | SIRT7 interactions | SRRM1 TCF20 PNN SUPT6H PRRC2C CKAP5 THOC2 NIPBL PRPF40A XRCC6 | 7.26e-05 | 744 | 61 | 10 | int:SIRT7 |
| Interaction | CHD3 interactions | SRRM1 ELOA MTF2 ZNF592 SUPT6H PRRC2C SHPRH CBX1 PRPF40A XRCC6 | 8.38e-05 | 757 | 61 | 10 | int:CHD3 |
| Interaction | XRCC6 interactions | ELOA TCF20 ATRX NF2 RBBP6 PECAM1 GPATCH11 CBX1 THOC2 PRPF40A XRCC6 | 9.40e-05 | 928 | 61 | 11 | int:XRCC6 |
| Interaction | TRIM37 interactions | 1.09e-04 | 630 | 61 | 9 | int:TRIM37 | |
| Interaction | BRD7 interactions | 1.19e-04 | 637 | 61 | 9 | int:BRD7 | |
| Interaction | SNRNP40 interactions | 1.19e-04 | 637 | 61 | 9 | int:SNRNP40 | |
| Interaction | PECAM1 interactions | 1.23e-04 | 32 | 61 | 3 | int:PECAM1 | |
| Interaction | SMG6 interactions | 1.28e-04 | 85 | 61 | 4 | int:SMG6 | |
| Interaction | H2BC4 interactions | 1.31e-04 | 259 | 61 | 6 | int:H2BC4 | |
| Interaction | CENPA interactions | 1.39e-04 | 377 | 61 | 7 | int:CENPA | |
| Interaction | SNRPF interactions | 1.58e-04 | 385 | 61 | 7 | int:SNRPF | |
| Interaction | PHF1 interactions | 1.73e-04 | 172 | 61 | 5 | int:PHF1 | |
| Interaction | EZH1 interactions | 1.74e-04 | 92 | 61 | 4 | int:EZH1 | |
| Interaction | CNGB1 interactions | 1.87e-04 | 7 | 61 | 2 | int:CNGB1 | |
| Interaction | PINK1 interactions | 1.92e-04 | 679 | 61 | 9 | int:PINK1 | |
| Interaction | NUPR1 interactions | 2.01e-04 | 683 | 61 | 9 | int:NUPR1 | |
| Interaction | FMR1 interactions | 2.03e-04 | 536 | 61 | 8 | int:FMR1 | |
| Interaction | TPR interactions | 2.03e-04 | 281 | 61 | 6 | int:TPR | |
| Interaction | NUAK1 interactions | 2.05e-04 | 96 | 61 | 4 | int:NUAK1 | |
| Interaction | TBK1 interactions | 2.06e-04 | 402 | 61 | 7 | int:TBK1 | |
| Interaction | PPP1R10 interactions | 2.08e-04 | 179 | 61 | 5 | int:PPP1R10 | |
| Interaction | PLOD2 interactions | 2.13e-04 | 180 | 61 | 5 | int:PLOD2 | |
| Interaction | SMC3 interactions | 2.25e-04 | 408 | 61 | 7 | int:SMC3 | |
| Interaction | HDAC2 interactions | JARID2 ELOA LIMA1 TCF20 TXNDC5 MTF2 PRRC2C ZNF423 CBX1 AHNAK2 | 2.49e-04 | 865 | 61 | 10 | int:HDAC2 |
| Interaction | ZNF311 interactions | 2.49e-04 | 8 | 61 | 2 | int:ZNF311 | |
| Interaction | DBN1 interactions | 2.57e-04 | 417 | 61 | 7 | int:DBN1 | |
| Interaction | WWTR1 interactions | 2.77e-04 | 422 | 61 | 7 | int:WWTR1 | |
| Interaction | ZC3H18 interactions | SRRM1 PNN RBBP6 PRRC2C CAMK2G NKTR THOC2 YTHDC1 PRPF40A XRCC6 | 2.78e-04 | 877 | 61 | 10 | int:ZC3H18 |
| Interaction | PPP1CC interactions | 3.55e-04 | 738 | 61 | 9 | int:PPP1CC | |
| Interaction | SUPT16H interactions | 3.66e-04 | 442 | 61 | 7 | int:SUPT16H | |
| Interaction | SRSF11 interactions | 3.72e-04 | 203 | 61 | 5 | int:SRSF11 | |
| Interaction | SART1 interactions | 3.88e-04 | 317 | 61 | 6 | int:SART1 | |
| Interaction | YAP1 interactions | LIMA1 MYH11 TCF20 NF2 PNN RBBP6 PRRC2C CKAP5 RAI14 THOC2 XRCC6 | 3.96e-04 | 1095 | 61 | 11 | int:YAP1 |
| Interaction | ZNF706 interactions | 3.99e-04 | 10 | 61 | 2 | int:ZNF706 | |
| Interaction | PRPF19 interactions | 4.07e-04 | 450 | 61 | 7 | int:PRPF19 | |
| Cytoband | 2q21.2 | 1.62e-04 | 14 | 62 | 2 | 2q21.2 | |
| Cytoband | 1q25.2 | 8.14e-04 | 31 | 62 | 2 | 1q25.2 | |
| GeneFamily | PHD finger proteins | 1.20e-06 | 90 | 38 | 5 | 88 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 1.87e-04 | 53 | 38 | 3 | 103 | |
| GeneFamily | Regulators of G-protein signaling | 8.81e-04 | 21 | 38 | 2 | 720 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | SP100 ATRX PNN RBBP6 SUPT6H CKAP5 THOC2 NIPBL PRPF40A IFIT3 AHNAK2 | 7.56e-07 | 721 | 61 | 11 | M10237 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 5.41e-06 | 417 | 61 | 8 | M39224 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP | 7.17e-06 | 200 | 61 | 6 | M4018 | |
| Coexpression | CHANDRAN_METASTASIS_UP | 9.22e-06 | 209 | 61 | 6 | M16036 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | JARID2 SRRM1 SP100 TCF20 PNN MTF2 RBBP6 PRRC2C NKTR THOC2 YTHDC1 PRPF40A IFIT3 | 1.55e-05 | 1394 | 61 | 13 | M9585 |
| Coexpression | RICKMAN_METASTASIS_UP | 1.67e-05 | 350 | 61 | 7 | M9752 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.12e-05 | 363 | 61 | 7 | M41103 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CEP350 JARID2 RGS14 PAG1 ATRX PNN RBBP6 PECAM1 KMT2E YTHDC1 NIPBL PRPF40A XRCC6 | 3.16e-05 | 1492 | 61 | 13 | M40023 |
| Coexpression | WANG_CLIM2_TARGETS_DN | 6.63e-05 | 182 | 61 | 5 | M8577 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN | 9.41e-05 | 196 | 61 | 5 | M9590 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 9.64e-05 | 197 | 61 | 5 | M3343 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP | 1.01e-04 | 199 | 61 | 5 | M9600 | |
| Coexpression | HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP | 1.03e-04 | 39 | 61 | 3 | M2550 | |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN | 1.03e-04 | 200 | 61 | 5 | M9957 | |
| Coexpression | STONER_ESOPHAGEAL_CARCINOGENESIS_DN | 1.11e-04 | 7 | 61 | 2 | M1444 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.53e-04 | 856 | 61 | 9 | M4500 | |
| Coexpression | AIZARANI_LIVER_C31_KUPFFER_CELLS_5 | 1.78e-04 | 120 | 61 | 4 | M39130 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | 1.84e-04 | 877 | 61 | 9 | M2241 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 1.87e-04 | 227 | 61 | 5 | M11234 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CEP350 JARID2 SRRM1 DONSON NRCAM TRAF3IP1 ATRX PNN RBBP6 CKAP5 CBX1 UPF3B THOC2 NIPBL PRPF40A CFAP97 | 3.33e-07 | 1257 | 61 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ELOA TCF20 TRAF3IP1 ATRX PNN RBBP6 GPATCH11 CBX1 NKTR NIPBL CFAP97 SMG6 | 1.85e-06 | 780 | 61 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CEP350 JARID2 SRRM1 DONSON NRCAM TRAF3IP1 ATRX PNN RBBP6 CKAP5 CBX1 UPF3B THOC2 NIPBL PRPF40A CFAP97 | 2.40e-06 | 1459 | 61 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ELOA TCF20 TRAF3IP1 ATRX PNN RBBP6 GPATCH11 CKAP5 NCKAP5 NKTR UPF3B NIPBL | 3.55e-06 | 831 | 61 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.48e-06 | 339 | 61 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SRRM1 TRAF3IP1 ATRX PNN SUPT6H CKAP5 PRKAG2 NIPBL PRPF40A IFIT3 | 1.12e-05 | 629 | 61 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.28e-05 | 298 | 61 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.99e-05 | 311 | 61 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | JARID2 SRRM1 LIMA1 DONSON ATRX PNN CKAP5 CBX1 UPF3B THOC2 NIPBL PRPF40A CFAP97 | 4.52e-05 | 1252 | 61 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.35e-05 | 151 | 61 | 5 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | JARID2 SP100 NRCAM TRAF3IP1 ATRX PNN CKAP5 ZFHX2 NCKAP5 UPF3B NIPBL | 1.01e-04 | 986 | 61 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.04e-04 | 379 | 61 | 7 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SP100 NRCAM TRAF3IP1 ATRX PNN RBBP6 CKAP5 ZFHX2 NCKAP5 UPF3B NIPBL | 1.04e-04 | 989 | 61 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.35e-04 | 532 | 61 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.26e-04 | 192 | 61 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.33e-04 | 432 | 61 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.55e-04 | 107 | 61 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_100 | 2.88e-04 | 9 | 61 | 2 | gudmap_kidney_adult_RenalCapsule_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.42e-04 | 210 | 61 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.82e-04 | 469 | 61 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 3.99e-04 | 790 | 61 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 4.18e-04 | 795 | 61 | 9 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 4.18e-04 | 795 | 61 | 9 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 4.26e-04 | 797 | 61 | 9 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 4.34e-04 | 799 | 61 | 9 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | 4.42e-04 | 801 | 61 | 9 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 4.83e-04 | 811 | 61 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 5.01e-04 | 815 | 61 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 5.14e-04 | 818 | 61 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.18e-04 | 230 | 61 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.47e-04 | 498 | 61 | 7 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 5.47e-04 | 498 | 61 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 6.41e-04 | 241 | 61 | 5 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_100 | 7.22e-04 | 14 | 61 | 2 | gudmap_kidney_adult_RenMedVasc_Tie2_k2_100 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_100 | 7.22e-04 | 14 | 61 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_k1_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.44e-04 | 378 | 61 | 6 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.15e-04 | 533 | 61 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.85e-04 | 259 | 61 | 5 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 9.13e-04 | 150 | 61 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 9.49e-04 | 16 | 61 | 2 | gudmap_kidney_adult_CortVasc_Tie2_k4_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.04e-03 | 403 | 61 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.13e-03 | 564 | 61 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.16e-03 | 275 | 61 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.18e-03 | 413 | 61 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.21e-03 | 162 | 61 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.33e-03 | 166 | 61 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_100 | 1.35e-03 | 19 | 61 | 2 | gudmap_kidney_adult_Mesangium_Meis_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.48e-03 | 291 | 61 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_100 | 1.49e-03 | 20 | 61 | 2 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.53e-03 | 435 | 61 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.54e-03 | 595 | 61 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | CEP350 ATRX PNN RBBP6 PRRC2C NKTR UPF3B THOC2 YTHDC1 PRPF40A SMG6 | 3.58e-15 | 197 | 62 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | CEP350 SRRM1 ZNF106 SP100 LIMA1 ATRX PRRC2C KMT2E NIPBL CFAP97 | 2.01e-13 | 199 | 62 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.01e-13 | 199 | 62 | 10 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.11e-13 | 200 | 62 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-10 | 191 | 62 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-10 | 191 | 62 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-10 | 191 | 62 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.23e-10 | 197 | 62 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.37e-10 | 198 | 62 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.37e-10 | 198 | 62 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.50e-10 | 199 | 62 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.50e-10 | 199 | 62 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.65e-10 | 200 | 62 | 8 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.15e-08 | 198 | 62 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-08 | 199 | 62 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.19e-08 | 199 | 62 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.23e-08 | 200 | 62 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.98e-08 | 138 | 62 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 176 | 62 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 178 | 62 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-07 | 184 | 62 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-07 | 185 | 62 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 185 | 62 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-07 | 187 | 62 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 188 | 62 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-07 | 194 | 62 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.47e-07 | 199 | 62 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.47e-07 | 199 | 62 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 173 | 62 | 5 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 174 | 62 | 5 | 9eab43885496b8586f8ec5b4bcb1fd5b209218e5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.12e-06 | 186 | 62 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.44e-06 | 188 | 62 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.78e-06 | 190 | 62 | 5 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | droplet-Thymus-nan-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-06 | 193 | 62 | 5 | 81871f4f2b63ca5f64a9ff12f6c909a34bf52216 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-06 | 193 | 62 | 5 | 12380713db6582749183a19de65d4af9d6469a3f | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.32e-06 | 193 | 62 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 7.32e-06 | 193 | 62 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 8.08e-06 | 197 | 62 | 5 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.28e-06 | 198 | 62 | 5 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.70e-06 | 200 | 62 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-05 | 152 | 62 | 4 | eee86b508b8f140ea44e21d8c04c409a7b689e39 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.04e-05 | 169 | 62 | 4 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-05 | 169 | 62 | 4 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 170 | 62 | 4 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 170 | 62 | 4 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.25e-05 | 170 | 62 | 4 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 170 | 62 | 4 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 178 | 62 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 179 | 62 | 4 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 181 | 62 | 4 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 182 | 62 | 4 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.20e-04 | 182 | 62 | 4 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 182 | 62 | 4 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.23e-04 | 183 | 62 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 183 | 62 | 4 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 186 | 62 | 4 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 62 | 4 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.36e-04 | 188 | 62 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-04 | 188 | 62 | 4 | 15d8dc514d5da46f6af284e7c1c92c606712dae6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 188 | 62 | 4 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 188 | 62 | 4 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 1.39e-04 | 189 | 62 | 4 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 189 | 62 | 4 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 190 | 62 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 190 | 62 | 4 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 191 | 62 | 4 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 192 | 62 | 4 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.48e-04 | 192 | 62 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.48e-04 | 192 | 62 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.48e-04 | 192 | 62 | 4 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.51e-04 | 193 | 62 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-04 | 193 | 62 | 4 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-04 | 194 | 62 | 4 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 194 | 62 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.54e-04 | 194 | 62 | 4 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.57e-04 | 195 | 62 | 4 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.57e-04 | 195 | 62 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.60e-04 | 196 | 62 | 4 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.60e-04 | 196 | 62 | 4 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 1.60e-04 | 196 | 62 | 4 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 196 | 62 | 4 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 197 | 62 | 4 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 197 | 62 | 4 | 89fe4885efc8db142c0dc0506840ae8aceba9ef9 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.36e-08 | 177 | 61 | 8 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.85e-07 | 178 | 61 | 7 | 3998_DN | |
| Drug | urapidil | 7.06e-06 | 2 | 61 | 2 | ctd:C015568 | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.86e-06 | 184 | 61 | 6 | 3244_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.11e-05 | 188 | 61 | 6 | 6735_DN | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.33e-05 | 194 | 61 | 6 | 5328_DN | |
| Drug | Rec 15/2739 | 2.11e-05 | 3 | 61 | 2 | CID000148842 | |
| Drug | (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane | 2.11e-05 | 3 | 61 | 2 | ctd:C010654 | |
| Drug | JB-788 | 2.11e-05 | 3 | 61 | 2 | ctd:C554161 | |
| Drug | Succimer | RGS18 TRAF3IP1 ATRX PNN MTF2 RBBP6 NKTR MLLT10 KMT2E THOC2 PRPF40A IFIT3 AHNAK2 | 2.42e-05 | 1264 | 61 | 13 | ctd:D004113 |
| Drug | Magnetite Nanoparticles | RGS18 TRAF3IP1 ATRX PNN MTF2 RBBP6 NKTR MLLT10 KMT2E THOC2 PRPF40A IFIT3 AHNAK2 | 3.52e-05 | 1310 | 61 | 13 | ctd:D058185 |
| Drug | propyl | 3.96e-05 | 71 | 61 | 4 | CID000123145 | |
| Drug | 5-methylurapidil | 4.22e-05 | 4 | 61 | 2 | ctd:C057446 | |
| Drug | Ergoloid mesylate | 4.22e-05 | 4 | 61 | 2 | DB01049 | |
| Disease | MASA syndrome (implicated_via_orthology) | 8.20e-05 | 7 | 59 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | comparative body size at age 10, self-reported | 1.91e-04 | 420 | 59 | 6 | EFO_0009819 | |
| Disease | Clear Cell Meningioma | 2.56e-04 | 12 | 59 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 2.56e-04 | 12 | 59 | 2 | C1334271 | |
| Disease | Benign Meningioma | 2.56e-04 | 12 | 59 | 2 | C0281784 | |
| Disease | Meningiomas, Multiple | 2.56e-04 | 12 | 59 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 2.56e-04 | 12 | 59 | 2 | C0457190 | |
| Disease | Mitral valve prolapse, response to surgery | 2.56e-04 | 12 | 59 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Angiomatous Meningioma | 2.56e-04 | 12 | 59 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 2.56e-04 | 12 | 59 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 2.56e-04 | 12 | 59 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 2.56e-04 | 12 | 59 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 2.56e-04 | 12 | 59 | 2 | C0334609 | |
| Disease | Intraorbital Meningioma | 2.56e-04 | 12 | 59 | 2 | C1334261 | |
| Disease | Transitional Meningioma | 2.56e-04 | 12 | 59 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 2.56e-04 | 12 | 59 | 2 | C0334610 | |
| Disease | Olfactory Groove Meningioma | 2.56e-04 | 12 | 59 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 2.56e-04 | 12 | 59 | 2 | C1527197 | |
| Disease | Spinal Meningioma | 2.56e-04 | 12 | 59 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 2.56e-04 | 12 | 59 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 2.56e-04 | 12 | 59 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 2.56e-04 | 12 | 59 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 2.56e-04 | 12 | 59 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 2.56e-04 | 12 | 59 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 2.56e-04 | 12 | 59 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 2.56e-04 | 12 | 59 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 2.56e-04 | 12 | 59 | 2 | C1384408 | |
| Disease | Secretory meningioma | 2.56e-04 | 12 | 59 | 2 | C1384406 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 4.81e-04 | 76 | 59 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Meningioma | 6.58e-04 | 19 | 59 | 2 | C0025286 | |
| Disease | malignant astrocytoma (is_marker_for) | 9.68e-04 | 23 | 59 | 2 | DOID:3069 (is_marker_for) | |
| Disease | beta-aminoisobutyric acid measurement | 1.05e-03 | 24 | 59 | 2 | EFO_0010464 | |
| Disease | age at menarche | 1.18e-03 | 594 | 59 | 6 | EFO_0004703 | |
| Disease | isthmus cingulate cortex volume measurement | 1.24e-03 | 26 | 59 | 2 | EFO_0010310 | |
| Disease | Mental Retardation, X-Linked | 1.54e-03 | 29 | 59 | 2 | C1136249 | |
| Disease | pulse pressure measurement | 1.69e-03 | 1392 | 59 | 9 | EFO_0005763 | |
| Disease | red blood cell density measurement | 1.81e-03 | 880 | 59 | 7 | EFO_0007978 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.96e-03 | 445 | 59 | 5 | EFO_0004314, GO_0097366 | |
| Disease | Antihypertensive use measurement | 1.96e-03 | 265 | 59 | 4 | EFO_0009927 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGTKHKTILEARSGL | 221 | Q96PM9 | |
| RKGKKSTFRHVGDDT | 836 | Q86US8 | |
| DLEGSGKHSSRKVDS | 51 | Q9UGJ0 | |
| GKEKHEPDVSSKSSS | 311 | Q9P2B7 | |
| RGLKSGLKTDKSDSE | 216 | P35348 | |
| ETGGKRHESSSEKKE | 146 | P20930 | |
| EGTSHEFKIKGRKAS | 366 | Q9Y483 | |
| KKGASATKHDSEGKT | 41 | Q9P0K7 | |
| RKHDKVTDKGSESGT | 336 | Q6ZWB6 | |
| NREHDKPEKKSASSG | 296 | Q8TDR0 | |
| DGKTKSLSRAHKTSG | 3231 | Q9NZR2 | |
| KESKGETGKRSKEGH | 656 | Q9UHB6 | |
| SDAEDHKPLKKGSRT | 1226 | Q92823 | |
| DTSGLERSHKSSKGG | 656 | Q9H307 | |
| SSAESHKDLGKKDTE | 696 | P16284 | |
| RNEHGIKSDSSKTDK | 851 | Q6KC79 | |
| LLSDHRKDKDSGGES | 1271 | Q8IZD2 | |
| DEKITGTPRKAHSKS | 1081 | Q7Z6E9 | |
| SDRGGSSKHNTIKKL | 566 | P35240 | |
| GSDSDDDDSHSKKKR | 831 | O75400 | |
| RDKGKKAESTESIGS | 401 | Q9BZI7 | |
| GSKSDKETEKGASRI | 1806 | Q14008 | |
| NKSTGGEHKKSDRKE | 486 | P46100 | |
| TGKSGIGHEASLKRK | 131 | Q8N954 | |
| SSGVKKEKDREGSSL | 321 | Q14241 | |
| HGLEGLSISKKSTDK | 381 | O14879 | |
| RKSSSKKDEEHILSG | 241 | Q8IXQ4 | |
| QKTAHETDKSEGGKR | 71 | P83916 | |
| KAERGSHQGKKSGTS | 1201 | Q5VT06 | |
| KKVEKTGADTRHGAS | 231 | P08908 | |
| KDGVRDESFHLKSSG | 196 | Q86Y33 | |
| KESGHKKETASGTSL | 331 | Q9NYP3 | |
| DGGVKKRKSSSSVHL | 326 | Q13555 | |
| GSHDGSSTVADGKKK | 1111 | Q92833 | |
| GGEKSSALHTKGKIE | 321 | Q2TB90 | |
| RKSSTVPGKHEKDSL | 1161 | O14513 | |
| EKKRKKPTHSEGSDS | 186 | P30414 | |
| LKTEKSSEEDLSGKH | 1056 | P30414 | |
| IGTLKETHERKGSDK | 301 | Q86YW0 | |
| IHESASDKDSLSKGK | 1271 | Q9Y520 | |
| LRSSEEHKGKLKTDS | 1051 | Q149N8 | |
| LEKGHSGKAKSTSAS | 196 | Q9NWQ8 | |
| KHTKTGREKATEDTE | 596 | Q8IVF2 | |
| DVSETRGSEGKGKKS | 306 | P55197 | |
| SHKGKKDTSITGELE | 201 | P35749 | |
| GDSEDDVGHKKRKRT | 76 | Q7KZ85 | |
| EEELKTHISKGTLGK | 561 | P12956 | |
| DKISSGGKKESRHDK | 1551 | Q8NI27 | |
| SSGGKEEKKHHKSSD | 1576 | Q8NI27 | |
| KRKHEDGSLSPTGSE | 1831 | Q9C0A1 | |
| HGSGKEETSKEAKIR | 26 | Q9NS28 | |
| VGDALKDHASKSRGK | 231 | Q9HCF6 | |
| SGKVTKHKGTEKRES | 436 | Q8IYB3 | |
| GHTKDLSGPTKESSK | 306 | Q92610 | |
| AEASSGALRSKHGEK | 416 | P23497 | |
| KSESHRKSLGSTEGE | 281 | O43566 | |
| KGRLLHSSKEGADKA | 1281 | Q9UGU0 | |
| RSGSGTDGSDEKKKE | 286 | Q96MU7 | |
| QRGKLGDGKEHTKSS | 896 | Q96JE7 | |
| EKSRKSNDGGKVLSH | 356 | Q8TF39 | |
| KKVSEHSGGRDLDSL | 406 | Q8NBS9 | |
| DDGSRKKAEFIKGSH | 916 | Q2M1K9 | |
| LDSSEKESKAGVGKR | 171 | A0A1B0GUJ8 | |
| SGHRKSETEKESGLK | 761 | Q9H2Y7 |